Background and Aim: The aim of the present prospective study was to evaluate tumor recurrence (intrasubsegmental recurrence-free survival and local tumor recurrence-free survival) and hepatic functional reserve following no-touch ablation. Methods: The prospective cohort study protocols were approved by the institutional ethics committee. All patients provided written, informed consent. Between January 2014 and September 2016, 231 patients with 277 hepatocellular carcinoma nodules were prospectively enrolled. An internally cooled bipolar electrode was used for no-touch ablation, while a monopolar electrode was used for direct puncture ablation. The intrasubsegmental recurrence-free survival rate was the primary end-point. The secondary outcomes were the local recurrence-free survival rate, the disease-free survival rate, and the changes in the Child-Pugh score. Results: No-touch ablation resulted in significantly higher cumulative intrasubsegmental tumor recurrence-free survival rates than direct puncture ablation (98.0% vs 87.1% at 1 year, 96.9% vs 76.8% at 2 years, and 91.0% vs 68.3% at 3 years, P < 0.001). The no-touch group also showed significantly better local recurrence-free survival and disease-free survival. Even when only primary cases were analyzed, the same results were obtained. To adjust for differences in the background characteristics, inverse probability of treatment weighting adjustment was performed. Only intrasubsegmental tumor recurrencefree survival was significantly better in the no-touch group (hazard ratio [HR], 0.08; 95% confidence interval [CI], 0.02-0.20, P < 0.001); there was no difference in local tumor recurrence-free survival (HR, 0.36; 95% CI, 0.10-1.02, P = 0.071). Conclusions: No-touch ablation appears to be an ideal method for the prevention of intrahepatic dissemination.
Introduction
Radiofrequency ablation (RFA) has spread widely as a curative and minimally invasive method for early stage hepatocellular carcinoma (HCC). [1] [2] [3] If the ablation area covers the blood drainage area where satellite lesions of HCC often occur, local tumor progression is very rare. 4 A single puncture with monopolar RF technology as the conventional method shows limited ability to reliably create a volume of coagulation necrosis. The major problem for monopolar RFA is that the electrical current flows between the electrode and the grounding pads. 5 Low energy efficiency requires a long ablation time. Therefore, to acquire an appropriate coagulation area using a monopolar electrode, multiple overlapping ablations are required. 6 To overcome these problems with monopolar RF technology, multipolar RFA using bipolar electrodes has been used. 5, 7, 8 Recently, the no-touch multi-bipolar technique without direct puncturing of the tumor has become available. Several retrospective studies reported that no-touch multi-bipolar ablation reduced local or intrasubsegmental recurrence. 8, 9 Although Hocquelet et al. reported good local tumor control by the no-touch technique with no increase in severe complications as compared with monopolar RFA, 8 there has been no prospective study of clinical outcomes comparing no-touch RFA with conventional RFA.
The present prospective study aimed to clarify the rate of tumor recurrence (intrasubsegmental recurrence-free survival and local tumor recurrence-free survival) and hepatic functional reserve after no-touch ablation.
Methods
The study protocols were approved by the institutional ethics committee at each hospital. Informed consent was obtained from all patients. All tumors showed the typical pattern of HCC (i.e. hyperattenuation in the arterial phase of dynamic computed tomography [CT] and CT hepatic arteriography and hypoattenuation in the portal-venous phase of CT during arterial portography). The inclusion criteria were (i) ineligible for surgical resection/liver transplantation or had declined surgery, (ii) no extrahepatic metastasis/vascular invasion, (iii) no other malignancies that may determine patient prognosis, (iv) solitary HCC, < 4 cm in diameter or multinodular HCC, < 3 cm, fewer than 3 in number, (v) ChildPugh class A or B, and (vi) primary lesion or initial recurrence (more than 2 years after previous ablation). The exclusion criteria were (i) tumor not visualized on ultrasonography or not accessible percutaneously, (ii) total bilirubin concentration ≥ 3.0 mg/dL, (iii) platelet count < 50 × 10 9 /L or prothrombin activity < 50%; (iv) refractory ascites, (v) risk for enterobiliary reflux (previous endoscopic sphincterotomy or bilio-enteric anastomosis), (vi) proximity of the tumor to the gastrointestinal tract, or (vii) proximity of the tumor to the major bile ducts (right or left hepatic ducts or sectorial ducts). A total of 234 patients with 280 HCC nodules were initially enrolled in this study. Three patients with three nodules were excluded because direct puncture was performed by bipolar electrodes. Finally, between January 2014 and September 2016, 231 patients with 277 HCC nodules were enrolled (Fig. S1 ).
This study was a prospective comparative cohort study. Before treatment, the patients were provided detailed information about both the no-touch and direct puncture procedures. Patients were then assigned to either group according to their preference, subject to the institution's capabilities.
Radiofrequency ablation. No-touch ablation was performed with two or three internally cooled bipolar electrodes simultaneously and an RFA generator (CelonLabPower; Celon AG Medical Instruments, Germany). To avoid direct puncture of the tumor, ablation was performed by placing all electrodes around the tumor. 8 The distance between the electrodes was decided by the dosimetry table for this bipolar system. 5 During ablation, the high-frequency power output was automatically controlled by a resistance-controlled automatic power system (RCAP, Celon AG Medical Instruments). 5 When monopolar RFA was performed, a single internally cooled electrode with a 200-W generator (Cool-tip; Radionics, Burlington, MA, USA) was used. There was only one placement of the ablation needle and not overlapping ablations with multiple passes. In cases with multiple nodules, all nodules were treated in the same session. Dynamic CT was performed 3-5 days after treatment. The necrotic area of the HCC nodule and surrounding liver parenchyma was visualized to be hypoattenuating during the late phases of dynamic CT. Repeated dynamic CT or MRI was performed every 3 months thereafter, and α-fetoprotein (AFP) and des-γ-carboxy prothrombin assays were performed before treatment, 1 month after treatment, and every subsequent month. To evaluate the ablation volume and safety margin, we used the 3D image analysis system (SYNAPSE VINCENT; Fuji Photo Film Co., Ltd., Japan) by using dynamic CT, which was performed 3-5 days after ablation. The width of the safety margin was measured between the external margin of the low-density area and the residual iodized oil.
Clinical outcome. The primary end-point of this study was the intrasubsegmental recurrence-free survival rate, which was compared between the no-touch ablation group and the direct puncture group to test the null hypothesis of no difference in the outcome. The secondary outcomes that were compared between the groups were the local recurrence-free survival rate, the disease-free survival rate, and the changes in the Child-Pugh score after treatment as compared to the pre-intervention score. Intrasubsegmental recurrence was defined as distant recurrence in the same subsegmental area as the original tumor, excluding local recurrence. A local recurrence was defined as a recurrence whose border was within 5 mm of the original nodule. Major complications based on the Society of Interventional Radiology criteria were analyzed as in a previous report. 10 The changes in the ChildPugh score were assessed.
Statistical analysis. Statistical analyses were performed using SAS version 9.4 (SAS Institute, Cary, NC, USA) and R (3.0.1). Quantitative variables are expressed as medians with first and third quartiles. To compare the clinical characteristics between the two groups, the Mann-Whitney U-test was used. Percentages were compared using the chi-squared test or Fisher's exact test, as appropriate. To assess survival curves, the Kaplan-Meier method was used. Multivariate Cox proportional hazard regression analysis was performed to predict the intrasubsegmental recurrence-free survival rate. Values of P < 0.05 were considered significant. To achieve sufficient power in the analysis of the primary end-point, more than 100 patients were required in each group to detect a difference in survival with 5% type-1 error and 80% power with a two-tailed log-rank test by Freedman's method.
To reduce possible selection bias between monopolar RFA and bipolar RFA, inverse probability of treatment weighting (IPTW) adjustment was performed. The propensity score (PS) was estimated by modeling the probability of receiving the no-touch ablation procedure. To determine the probability of receiving no-touch ablation, a multivariable logistic model was constructed with the following covariates: age, sex, etiology, tumor diameter, tumor number, and ablation volume. Using the logistic model, a PS was calculated for each individual. For the IPTW adjustment, weights for patients in the no-touch group were the inverse of the PS, and weights for patients in the direct puncture group were the inverse of (1-PS). These values were incorporated into the weighted Cox regression model to evaluate intrasubsegmental recurrence-free survival, disease-free survival, and local recurrence. Stabilized IPTWs were calculated to reduce the variability and ensure unbiased estimation of the treatment effect.
Results
Clinical characteristics of the no-touch and direct puncture groups. Table 1 presents the baseline characteristics of the two RFA treatment groups. The two groups were comparable with regard to age, sex, etiology, Child-Pugh score, platelet count, AFP, maximum tumor diameter, number of tumors, and onset (primary/recurrence). Maximum tumor diameter was significantly greater in the no-touch group (P < 0.001). The rate of primary lesions was higher in the no-touch group (P < 0.001). The ablation volume of the no-touch group was significantly larger than that of the direct puncture group (P < 0.001). There were no significant differences with regard to other factors. The median follow-up period was 759 days in the no-touch group and 885 in the direct puncture group (P = 0.201). The median follow-up period just after the end of enrollment was 175 days.
Intrasubsegmental tumor recurrence-free survival and local recurrence-free survival. The rate of complete radiological necrosis was 100% in both groups. Cumulative intrasubsegmental tumor recurrence-free survival rates were significantly higher with no-touch ablation than with direct puncture ablation (98.0% vs 87.1% at the first year, 96.9% vs 76.8% at the second year, and 91.0% vs 68.3% at the third year, respectively, P < 0.001, Fig. 1a , hazard ratio [HR], 0.11; 95% confidence interval [CI], 0.03-0.30; P < 0.001). Regarding predictive factors for intrasubsegmental tumor recurrence, no-touch ablation, ablation volume (HR, 0.35; 95% CI, 0.10-0.89; P = 0.026), and safety margin (< 5 mm vs > 10 mm: HR, 3.56; 95% CI, 1.26-9.61; P = 0.018) were associated factors on univariate analysis. The number of tumors tended to be an associated factor (HR, 1.96; 95% CI, 0.92-3.95; P = 0.079), while the institution at which treatment was received was not an associated factor. In the multivariate Cox proportional hazard model analysis, the no-touch procedure was the only independent factor for intrasubsegmental tumor recurrence-free survival (HR, 0.10; 95% CI, 0.02-0.33; P < 0.001), while ablation volume (HR, 0.80; 95% CI, 0.28-3.03; P = 0.714), safety margin (< 5 mm vs > 10 mm: HR, 1.60; 95% CI, 0.54-4.63; P = 0.387), and tumor number (HR, 1.69; 95% CI, 0.79-3.41; P = 0.168) were not independent factors (Table 2) . Cumulative local recurrence-free rates were significantly different between the two groups (no-touch and direct puncture: 98.0% vs 93.1% at the first year, 98.0% vs 89.4% at the second year, and 94.5% vs 88.0% at the third year, respectively, P < 0.001, Fig. 1b) . Regarding the predictors for local tumor recurrence, no-touch ablation (HR, 0.26; 95% CI, 0.06-0.81; P = 0.018) and ablation volume (HR, 0.17; 95% CI, 0.01-0.84; P = 0.026) were associated factors on univariate analysis. Male sex (HR, 0.40; 95% CI, 0.14-1.09; P = 0.072) and safety margin (< 5 mm vs > 10 mm: HR, 2.29; 95% CI, 0.92-8.83, P = 0.069) tended to be an associated factor. In the multivariate Cox proportional hazard model analysis, the no-touch procedure (HR, 0.37; 95% CI, 0.08-0.1.21; P = 0.107) and ablation volume (HR, 0.30; 95% CI, 0.58-5.00; P = 0.207) were not independent factors for local tumor recurrence-free survival (Table 3) .
In addition, primary cases were assessed separately. Cumulative intrasubsegmental tumor recurrence-free survival rates were significantly higher with no-touch ablation than with direct puncture ablation (98.6% vs 88.5% at 1 year, 98.6% vs 77.0% at 2 years, and 95.8% vs 68.3% at 3 years, respectively, P < 0.001, Fig. 2a ). Regarding predictors for intrasubsegmental tumor recurrence, no-touch ablation (HR, 0.10; 95% CI, 0.02-0.32; P < 0.001) was significant based on univariate analysis. Cumulative local recurrence-free rates were significantly different between the two groups (no-touch and direct puncture: 98.6% vs 95.3% at the first year, 98.6% vs 91.6% at the second year, and 98.6% vs 89.6% at the third year, respectively, P = 0.036, Fig. 2b ). Regarding predictors for local tumor recurrence, no-touch ablation (HR, 0.15; 95% CI, 0.01-0.80; P = 0.023) was significant based on univariate analysis. Cumulative overall survival rates were also not significantly different between the two groups (no-touch and direct puncture: 99.0% vs 95.7% at the first year, 95.6% vs 89.8% at the second year, and 93.3% vs 86.8% at the third year, P = 0.110). As for no-touch ablation, the hazard ratio was negatively associated (0.43; 95% CI, 0.11-1.26; P = 0.127).
Intrasubsegmental tumor recurrence-free survival and local recurrence-free survival assessed by the width of safety margin. Cumulative intrasubsegmental tumor recurrence-free survival rates were significantly higher with no-touch ablation than with direct puncture ablation (P < 0.001, Fig. 3a) . However, intrasubsegmental tumor recurrence-free survival rates were not significantly higher with a larger safety margin (> 10 mm) than with a smaller margin. Cumulative local recurrence-free rates were significantly lower with direct puncture with a smaller safety margin (< 5 mm) than other groups (P = 0.043, Fig. 3b ).
Changes in the Child-Pugh score and complications. The Child-Pugh scores before ablation were 5 (142/ 231), 6 (58/231), 7 (24/231), 8 (6/231), and 9 (1/231). Relative to scores before ablation, the numbers of patients with increased Child-Pugh scores were score 5, 25 (17.6%); score 6, 7 (12.1%); score 7, 4 (16.7%); score 8, 1 (16.7%); and score 9, 0. The number of patients with higher Child-Pugh scores was 17 in the no-touch group and 20 in the direct puncture group (P = 0.824). The number of patients with higher Child-Pugh scores was 10 (15.4%) with ablation volume < 40 mL and 27 (16.3%) with lower ablation volume (P = 0.870). Two patients (2.2%) required coiling for active bleeding due to puncture by a monopolar electrode (grade D, required major therapy and prolonged hospitalization [> 48 h]), while there was no patient with hemorrhage in the no-touch ablation group. Grade D ascites occurred in one patient in each of the two groups, and grade C ascites occurred in one patient in the notouch group and two in the direct puncture group. These complications were transient. Major complications, defined as grade E (permanent adverse sequelae) and grade F (death), did not occur.
Validation of the advantage of the no-touch procedure using inverse probability of treatment weighting adjustment. To control for confounders, statistical analysis using IPTW was performed to assess intrasubsegmental or local recurrence-free survival and diseasefree survival. Table 1 shows the patients' profiles after IPTW analysis. The results indicated that the baseline characteristics were not significantly different between the no-touch ablation and direct puncture groups. After adjustment, cumulative intrasubsegmental tumor recurrence-free rates were significantly higher with notouch ablation than with direct puncture ablation (no-touch and direct puncture: 99.5% vs 91.5% at the first year, 98.6% vs 79.8% at the second year, and 97.4% vs 75.8% at the third year, respectively, P < 0.001, HR, 0.08; 95% CI, 0.02-0.20, P < 0.001, Fig. 4a ). On the other hand, cumulative local recurrence-free rates were not significantly different between the two groups (no-touch and direct puncture: 98.8% vs 97.4% at the first year, 98.8% vs 94.5% at the second year, and 96.2% vs 93.6% at the third year, respectively, P = 0.060, HR, 0.36; 95% CI, 0.10-1.02, P = 0.072, Fig. 4b ).
Discussion
Hocquelet et al. have previously reported that the no-touch technique resulted in better local tumor control than the direct puncture technique in a retrospective study. 8 In our prospective study, monopolar ablation with direct puncture resulted in extrusion of cancer cells around the tumor, and intrasubsegmental recurrence occurred often.
As the HCC grows with the formation of a tumor capsule, portal venous flow decreases with a concomitant increase in hepatic arterial flow.
11 Drainage flows mainly into surrounding hepatic sinusoids and partially into portal veins according to the blood pressure gradient. 12 Therefore, the higher the tumor pressure, the easier intrasubsegmental metastasis occurs via drainage vessels. Tanaka et al. also reported that intrahepatic metastasis occurs more easily when tumor pressure increases. 13 It was thought that tumor cells disperse into the portal veins, leading to intrahepatic metastasis. Ueki et al. reported that tumor pressure was positively associated with local and distant recurrence after ethanol injection.
14 Elevation of tumor pressure after injection of ethanol may induce invasion into drainage vessels. It is thought that increased tumor pressure after direct puncture may be involved in the dispersal of tumor cells into the drainage portal bloodstream. Therefore, there are two advantages of the no-touch procedure. First, drainage portal veins or lymphatic vessels are damaged by ablation. Thus, a surgical procedure with lymphovascular ligation is performed by ablation. Second, because the ablated area spreads from the peripheral zone to the center, tumor cell spread is not facilitated as the tumor cells are shed into drainage vessels by the prevention of high intratumoral pressure after ablation (Fig. S2) . Before IPTW adjustment, local recurrence-free survival was significantly different by ablation volume. After adjustment, local recurrence-free survival was not significantly higher in the notouch group. Even with adjustment for ablation volumes, intrasubsegmental recurrence-free survival was still significantly better in the no-touch group. Thus, monopolar ablation with direct puncture facilitates shedding of tumor cells into the drainage portal flow.
One concern is whether hepatic functional reserve can be maintained after no-touch ablation. Hocquelet et al. reported that the rate of severe complications was high for patients with no-touch ablation. However, there were no patients with severe complications, defined as grade E (permanent adverse sequelae) and grade F (death) in the present cohort. The incidence of ascites did not differ between the two groups in the present study. Increases in the Child-Pugh score also did not differ between the two groups. If the ablation volume is about 40 mL, elevation of the Child-Pugh score does not occur with no-touch ablation. Hocquelet et al. have previously reported that the no-touch technique resulted in hemobilia (grade D), while one patient developed hemothorax in the direct puncture group. In the present study, it seemed that the no-touch technique was not more often associated with bleeding.
Kawamura et al. have reported cumulative intrasubsegmental and local recurrence rates. 9 Intrasubsegmental recurrence tended to be higher with direct puncture than with no-touch ablation (3.8% vs 2.9% at the first year, 13.8% vs 2.9% at the second year, and 16.3% vs 2.9% at the third year, P = 0.083). In contrast, local recurrence rates were not significantly different, as in the present study. Hocquelet et al. reported that the cumulative rates of global RF failure (both primary RFA and local tumor progression) at 1 and 3 years were respectively 13.3% and 31% for direct puncture Figure 3 Intrasubsegmental tumor recurrence-free survival and local recurrence-free survival assessed by the width of safety margin. Cumulative intrasubsegmental tumor recurrence-free survival rates (a) are significantly higher with no-touch ablation (brown and green lines) than with direct puncture ablation (blue and red lines). Intrasubsegmental tumor recurrence-free survival rates were not significantly higher with a larger safety margin (> 10 mm) than with a smaller margin. Cumulative local recurrence-free survival rates (b) was the same as intrasubsegmental tumor recurrence-free survival rates. [Color figure can be viewed at wileyonlinelibrary.com] Usefulness of no-touch ablationablation versus 0.02% and 7.9% for no-touch ablation. 8 Tateishi et al. have reported the intrasubsegmental recurrence rate including local recurrence for direct puncture ablation. 15 Cumulative rates of exclusively intrasubsegmental and simultaneously intrasubsegmental and extrasubsegmental recurrence were 3.4% and 7.1% at 1 year and 12.7% and 16.4% at 3 years, respectively. Although each cohort and the definition of recurrence were different, similar results were seen.
This study has several limitations. First, although this study was performed prospectively, patients were not randomly allocated. Moreover, allocation between no-touch and direct puncture groups was biased. Therefore, a randomized, controlled trial would be desirable in the future. PS matching was used as a last resort. Factors affecting treatment and outcome that cannot be observed cannot be considered in the matching procedure; thus, hidden differences in latent variables may remain even after matching. Second, we hypothesized a mechanism in which no-touch ablation was related to the tumor pressure after ablation, but elevation of tumor pressure during ablation was not confirmed. Third, it is impossible to confirm whether the electrodes were inserted into the tumor. In previous reports, detailed methods were not presented. 8, 16 In the present study, it was carefully confirmed that the electrodes were not inserted into tumor; 74.5% of the patients were treated with a simulation system. 7, 17 In conclusion, no-touch RFA with bipolar electrodes is an ideal method to prevent intrahepatic dissemination via drainage into the portal blood flow stream. 
Supporting information
Additional supporting information may be found online in the Supporting Information section at the end of the article. Figure S1 . Clinical profiles of the no-touch and direct puncture groups. Figure S2 . The mechanisms of intrasubsegmental recurrence. Table S1 . Predictors of disease-free survival.
Usefulness of no-touch ablation
